1,622
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Placental volume in pregnant women with opioid use: prenatal MRI assessment

, , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Article: 2157256 | Received 30 Aug 2022, Accepted 02 Dec 2022, Published online: 04 Jan 2023

References

  • Maeda A, Bateman BT, Clancy CR, et al. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology. 2014;121(6):1158–1165.
  • Hirai AH, Ko JY, Owens PL, et al. Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010–2017. JAMA. 2021;325(2):146–155.
  • Committee opinion no. 711: opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017;130(2):e81–e94.
  • Smith GC. First-trimester determination of complications of late pregnancy. JAMA. 2010;303(6):561–562.
  • Sun C, Groom KM, Oyston C, et al. The placenta in fetal growth restriction: what is going wrong? Placenta. 2020;96:10–18.
  • Brett KE, Ferraro ZM, Yockell-Lelievre J, et al. Maternal-fetal nutrient transport in pregnancy pathologies: the role of the placenta. Int J Mol Sci. 2014;15(9):16153–16185.
  • Effendi M, Demers S, Giguère Y, et al. Association between first-trimester placental volume and birth weight. Placenta. 2014;35(2):99–102.
  • Rosenfeld CS. The placenta as a target of opioid drugs. Biol Reprod. 2022;106(4):676–686.
  • Green MT, Martin RE, Kinkade JA, et al. Maternal oxycodone treatment causes pathophysiological changes in the mouse placenta. Placenta. 2020;100:96–110.
  • Serra AE, Lemon LS, Mokhtari NB, et al. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study. Am J Obstet Gynecol. 2017;216(4):418.e1–418.e5.
  • Staszewski C, Herrera KM, Kertowidjojo E, et al. Histological changes observed in placentas exposed to medication-assisted treatment. J Pregnancy. 2021;2021:2175026.
  • Radhakrishna U, Nath SK, Vishweswaraiah S, et al. Maternal opioid use disorder: placental transcriptome analysis for neonatal opioid withdrawal syndrome. Genomics. 2021;113(6):3610–3617.
  • Andescavage NN, Du Plessis A, Limperopoulos C. Advanced MR imaging of the placenta: exploring the in utero placenta-brain connection. Semin Perinatol. 2015;39(2):113–123.
  • Andescavage N, Kapse K, Lu YC, et al. Normative placental structure in pregnancy using quantitative magnetic resonance imaging. Placenta. 2021;112:172–179.
  • Capuani S, Guerreri M, Antonelli A, et al. Diffusion and perfusion quantified by magnetic resonance imaging are markers of human placenta development in normal pregnancy. Placenta. 2017;58:33–39.
  • León RL, Li KT, Brown BP. A retrospective segmentation analysis of placental volume by magnetic resonance imaging from first trimester to term gestation. Pediatr Radiol. 2018;48(13):1936–1944.
  • Neelavalli J, Krishnamurthy U, Jella PK, et al. Magnetic resonance angiography of fetal vasculature at 3.0 T. Eur Radiol. 2016;26(12):4570–4576.
  • Zaghal AA, Hussain HK, Berjawi GA. MRI evaluation of the placenta from normal variants to abnormalities of implantation and malignancies. J Magn Reson Imaging. 2019;50(6):1702–1717.
  • Radhakrishnan R, Brown BP, Haas DM, et al. Pilot study of fetal brain development and morphometry in prenatal opioid exposure and smoking on fetal MRI. J Neuroradiol. 2022;49(1):53–58.
  • R Core Team. R: a language and environment for statistical computing. Vienna: R Core Team; 2016. Available from: https://www.R-project.org/
  • Rubinchik-Stern M, Eyal S. Drug interactions at the human placenta: what is the evidence? Front Pharmacol. 2012;3:126.
  • Liu J, Grewen K, Gao W. Evidence for the normalization effects of medication for opioid use disorder on functional connectivity in neonates with prenatal opioid exposure. J Neurosci. 2022;42(22):4555–4566.
  • Janisse JJ, Bailey BA, Ager J, et al. Alcohol, tobacco, cocaine, and marijuana use: relative contributions to preterm delivery and fetal growth restriction. Subst Abus. 2014;35(1):60–67.
  • Bada HS, Das A, Bauer CR, et al. Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol. 2005;25(10):631–637.
  • Smith LM, LaGasse LL, Derauf C, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics. 2006;118(3):1149–1156.
  • Wikner BN, Stiller CO, Bergman U, et al. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf. 2007;16(11):1203–1210.
  • Mitsuda N, N Awn JP, Eitoku M, et al. Association between maternal active smoking during pregnancy and placental weight: the Japan environment and children’s study. Placenta. 2020;94:48–53.
  • Wang N, Tikellis G, Sun C, et al. The effect of maternal prenatal smoking and alcohol consumption on the placenta-to-birth weight ratio. Placenta. 2014;35(7):437–441.
  • McNamara H, Hutcheon JA, Platt RW, et al. Risk factors for high and low placental weight. Paediatr Perinat Epidemiol. 2014;28(2):97–105.
  • Er P, Ijr NA. Fetal gender-specific difference for placental volume assessed with 3D-ultrasonography. Perinatal Journal. 2016;24(3):156–161.
  • Clifton VL. Review: sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta. 2010;31 Suppl:S33–S39.